Back to search

Lymph node micrometastases from breast carcinoma

Data up to Jan 2025

Published1997
Citations431
References56

Total Citations Per Year

Abstract

References (56)

Technical Details of Intraoperative Lymphatic Mapping for Early Stage Melanoma

1992 • 4,391 citations

Lymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer

1994 • 2,837 citations

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy

1992 • 2,084 citations

Cancer statistics, 1996

1996 • 1,807 citations

Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe

1993 • 1,674 citations

Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update

1983 • 1,028 citations

Systemic Treatment of Early Breast Cancer by Hormonal, Cytotoxic, or Immune Therapy:133 Randomised Trials involoving 31 000 Recurrences and 24 000 Deaths Among 75 000 Women (Summary)

1993 • 967 citations

Improved Axillary Staging of Breast Cancer with Sentinel Lymphadenectomy

1995 • 936 citations

Prognostic importance of occult axillary lymph node micrometastases from breast cancers

1990 • 385 citations

Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction.

1995 • 366 citations

Significance of Axillary Macrometastases and Micrometastases in Mammary Cancer

1971 • 322 citations

Micrometastases to axillary lymph nodes from carcinoma of breast: Detection by immunohistochemistry and prognostic significance

1987 • 311 citations

Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up

1992 • 307 citations

Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction.

1994 • 271 citations

Detection and significance of occult axillary node metastases in patients with invasive breast cancer

1978 • 269 citations

Occult axillary node metastases in breast cancer: their detection and prognostic significance

1996 • 255 citations

Occult axillary lymph node metastases in “node-negative” breast carcinoma

1993 • 243 citations

The contribution of recent nsabp clinical trials of primary breast cancer therapy to an understanding of tumor biology—an overview of findings

1980 • 241 citations

Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil.

1996 • 240 citations

Significance of occult metastases.A study of breast cancer

1961 • 231 citations

Detection and significance of occult metastases in node-negative breast cancer

1993 • 228 citations

Predictors of axillary lymph node metastases in patients with T1 breast cancer. A multivariate analysis

1994 • 198 citations

Axillary Micro- and Macrometastases in Breast Cancer

1981 • 193 citations

Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification.

1996 • 187 citations

Predictors of Recurrence in Stage I (T1N0M0) Breast Carcinoma

1981 • 186 citations

Pathologic findings from the national surgical adjuvant breast project (protocol no. 4).V. significance of axillary nodal micro- and macrometastases

1978 • 186 citations

Obscure axillary lymph-node metastasis in carcinoma of the breast

1948 • 179 citations

The immunocytochemical detection of axillary micrometastases in breast cancer

1984 • 157 citations

Congenital absence of the vas.

1948 • 133 citations

Pathologic correlates of prognosis in lymph node-positive breast carcinomas

1993 • 122 citations

Oncogene Protein Co-Expression Value of Ha-ras, c-myc, c-fos, and p53 as Prognostic Discriminants for Breast Carcinoma

1995 • 118 citations

Occult axillary lymph node metastases in invasive breast carcinoma: characteristics of the primary tumor and significance of the metastases.

1982 • 115 citations

Importance of Tumor Cells in Axillary Node Sinus Margins (‘Clandestine’ Metastases) Discovered by Serial Sectioning in Operable Breast Carcinoma

1988 • 114 citations

The use of antisera to epithelial membrane antigen in detecting micrometastases in histological sections

1980 • 108 citations

The immunohistochemical detection of lymph node metastases from infiltrating lobular carcinoma of the breast

1987 • 104 citations

Histochemical and Immunohistochemical Techniques

1991 • 84 citations

Occult metastases in the axillary lymph nodes of patients with breast cancer node negative by clinical and histologic examination and conventional histology.

1991 • 75 citations

Occult regional lymph node metastases from breast carcinoma: Immunohistological detection with antibodies CAM 5.2 and NCRC‐11

1991 • 73 citations

Micrometastases to axillary lymph nodes from invasive lobular carcinoma of breast: Detection by immunohistochemistry and prognostic significance

1987 • 68 citations

Prognosis in Stage II “T1N1M0”Breast Cancer

1981 • 67 citations

Axillary micrometastasis and macrometastasis in carcinoma of the breast.

1977 • 55 citations

Detection of metastatic breast carcinoma with monoclonal antibodies to cytokeratins.

1989 • 49 citations

The use of monoclonal antibodies for the histopathological detection of mammary axillary micrometastases.

1987 • 49 citations

Occult axillary lymph node metastases from breast cancers with intramammary lymphatic tumor emboli

1982 • 46 citations

Immunoperoxidase staining in the detection of lymph node metastases in stage i breast cancer

1989 • 45 citations

A preliminary report on the usefulness of monoclonal antibodies to CA 15-3 and MCA in the detection of micrometastases in axillary lymph nodes draining primary breast carcinoma

1992 • 44 citations

Systemic therapy in node-negative patients: updated findings from NSABP clinical trials. National Surgical Adjuvant Breast and Bowel Project.

1992 • 43 citations

Immunohistochemical detection and significance of axillary lymph node micrometastases in breast carcinoma. A study of 97 cases.

1993 • 36 citations

The Reliability of Histologically Negative Axillary Lymph Nodes in Breast Cancer

1988 • 34 citations

Obscure axillary lymph node metastases in carcinoma of the breast.

1948 • 34 citations

THE SEARCH FOR OCCULT METASTASES IN BREAST CANCER: DOES IT ADD TO ESTABLISHED STAGING METHODS?

1980 • 29 citations

Comparison of the Detection of Breast Carcinoma Metastases by Routine Histological Diagnosis and by Immunohistochemical Staining

1988 • 25 citations

TOXIC EFFECTS OF EARLY ADJUVANT CHEMOTHERAPY FOR BREAST CANCER

1983 • 23 citations

PROGNOSTIC SIGNIFICANCE OF c‐erbB‐2 ONCOGENE IN AXILLARY NODE‐NEGATIVE BREAST CANCER

1996 • 19 citations

Detection of breast cancer micrometastases in axillary lymph nodes using the polymerase chain reaction (PCR)

1993 • 12 citations

A single perioperative adjuvant chemotherapy course for node-negative breast cancer: five-year results of trial V. International Breast Cancer Study Group (formerly Ludwig Group).

1992 • 9 citations

Cited By (0)

No citing papers found in database

Lymph node micrometastases from breast carcinoma (1997) – Cancer | Metascience Observatory Explorer